Skip to content

A randomized controlled double-blind multicenter clinical study evaluating Miao medicine Guyanxiao plaster for the treatment of knee osteoarthritis using non-medicated Guyanxiao plaster as the control

A randomized controlled double-blind multicenter clinical study evaluating Miao medicine Guyanxiao plaster for the treatment of knee osteoarthritis using non-medicated Guyanxiao plaster as the control

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001657
Enrollment
Unknown
Registered
2025-09-03
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Experimental group:Guyanxiao plaster
Control group:placebo

Sponsors

The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for knee osteoarthritis according to both Western medicine and Traditional Chinese Medicine; 2. Aged between 50 and 75 years regardless of gender; 3. Knee pain severity score (NRS) = 4 points; 4. Patients classified as grade I-III according to the K-L grading system; 5. Voluntarily sign the informed consent form and be able to cooperate with the treatment.

Exclusion criteria

Exclusion criteria: Anyone who meets any of the following conditions is not eligible to participate in this study: 1. Those with severe dysfunction of the heart liver kidneys or other organs; 2. Those with damaged ulcerated skin at the affected area or concurrent skin diseases; 3. Those allergic to the components of the investigational drug; 4. Those who have recently undergone other knee joint treatments (such as surgery intra-articular injections etc.). 5. Those who have recently taken non-steroidal anti-inflammatory drugs.

Design outcomes

Primary

MeasureTime frame
NRS score after 14 days of treatment;Knee WOMAC score after 14 days of treatment;

Secondary

MeasureTime frame
Numerical Rating Scale;Knee WOMAC score after 7 days of treatment;Knee range of motion;The degree of joint swelling;

Countries

China

Contacts

Public ContactQuan Sun

No. 71 Baoshan North Road Yunyan District Guiyang City

59801666@qq.com13765080356

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026